Moviprep

Ascorbic acid, the active ingredient in Moviprep, is an osmotic laxative presented as a powder for oral solution for oral use. It is used to cleanse the bowel in adults undergoing colonoscopy or sigmoidoscopy. GNH USA supplies Moviprep as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Moviprep, an osmotic laxative, is employed for bowel preparation in gastrointestinal endoscopic procedures. - Colonoscopy: provides thorough bowel cleansing to allow clear visualization of the colon. - Sigmoidoscopy: clears the distal colon and rectum for accurate examination. - CT colonography: prepares the colon for radiologic imaging by removing fecal material.

Common Side Effects: - Nausea: mild to moderate feeling of sickness. - Abdominal cramping: intermittent discomfort during evacuation. - Bloating: sensation of abdominal fullness. - Vomiting: occasional expulsion of stomach contents. - Thirst: increased desire for fluids. - Headache: transient mild headache.

Serious or Rare Side Effects: - Severe dehydration: marked fluid loss requiring medical attention. - Electrolyte imbalance: especially hypokalemia or hyponatremia. - Acute renal impairment: sudden decline in kidney function. - Allergic reaction: rash, itching, swelling, or angioedema. - Severe abdominal pain: persistent intense pain.

Before using Moviprep, consider the following precautions: - Renal function assessment: evaluate kidney health to avoid worsening impairment. - Electrolyte monitoring: check serum electrolytes, especially potassium and sodium. - Adequate hydration: ensure sufficient fluid intake to reduce dehydration risk. - Hypersensitivity: avoid if known allergy to any component. - Pediatric use: not recommended for children unless specifically prescribed. - Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Moviprep may interact with other medicines as follows: Major Interactions (Avoid): - Lithium therapy: increased lithium levels may cause toxicity. - Loop diuretics: combined effect can lead to severe electrolyte depletion. - ACE inhibitors or ARBs: risk of renal dysfunction when dehydration occurs. Moderate Interactions (Monitor Closely): - NSAIDs: may exacerbate renal impairment in dehydrated patients. - Other laxatives: additive laxative effect can cause excessive fluid loss. - Oral rehydration salts: may alter the intended osmotic balance of the preparation.